Expanded criteria donor kidneys where the paired kidney is discarded owing to biopsy results: A concept that needs revision

Experimental and Clinical Transplantation

Volumn 12, Issue 6, 2014, Pages 499-505

  Bodzin, Adam S ^a   Leiby, Benjamin E ^b   Ramirez, Carlo B ^b   Frank, Adam M ^b   Doria, Cataldo ^b  

^a UCLA MEDICAL CENTER   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Acute tubular necrosis; Glomerulosclerosis; Transplantation

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DATA BASE; EXPLORATORY RESEARCH; FEMALE; FUNCTIONAL ASSESSMENT; GLOMERULOSCLEROSIS; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; SURVIVAL TIME; SYSTEMIC DISEASE; ADVERSE EFFECTS; BIOPSY; CLASSIFICATION; COMPLICATION; DONOR; DONOR SELECTION; GLOMERULONEPHRITIS; HOSPITAL ADMISSION; KAPLAN MEIER METHOD; KIDNEY; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; SUPPLY AND DISTRIBUTION; TIME; TREATMENT OUTCOME;

BIOPSY; DONOR SELECTION; FEMALE; GLOMERULONEPHRITIS; GRAFT SURVIVAL; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TISSUE DONORS; TREATMENT OUTCOME; WAITING LISTS;

EID: 84916641904     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: 10.6002/ect.2014.0021     Document Type: Article

References (26)

1. Organ Procurement and Transplant Network. Transplants by donor type. http://optn.transplant.hrsa.gov/. Accessed Sept 14, 2012.
2. Scientific Registry of Transplant Recipients. 2009 Annual Report, Table 5.4. http://www.ustransplant.org/-annual_reports/current/. Accessed April 21, 2011.
3. Port FK, Bragg-Gresham JL, Metzger RA, et al. Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors. Transplantation. 2002;74(9):1281-1286.
4. Ojo AO, Hanson JA, Meier-Kriesche H, et al. Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol. 2001;12(3):589-597.
5. Sung RS, Galloway J, Tuttle-Newhall JE, et al. Organ donation and utilization in the United States, 1997-2006. Am J Transplant. 2008;8(4 Pt 2):922-934.
6. Sung RS, Christensen LL, Leichtman AB, et al. Determinants of discard of expanded criteria donor kidneys: impact of biopsy and machine perfusion. Am J Transplant. 2008;8(4):783-792.
7. Gaber LW, Moore LW, Alloway RR, Amiri MH, Vera SR, Gaber AO. Glomerulosclerosis as a determinant of posttransplant function of older donor renal allografts. Transplantation. 1995;60(4):334-339.
8. Metzger RA, Delmonico FL, Feng S, Port FK, Wynn JJ, Merion RM. Expanded criteria donors for kidney transplantation. Am J Transplant. 2003;3(suppl 4):114-125.
9. Pokorná E, Vítko S, Chadimová M, Schück O, Ekberg H. Proportion of glomerulosclerosis in procurement wedge renal biopsy cannot alone discriminate for acceptance of marginal donors. Transplantation. 2000;69(1):36-43.
10. Edwards EB, Posner MP, Maluf DG, Kauffman HM. Reasons for non-use of recovered kidneys: the effect of donor glomerulosclerosis and creatinine clearance on graft survival. Transplantation. 2004;77(9):1411-1415. Erratum in: Transplantation. 2004;77(11):1776.
11. Stratta RJ, Rohr MS, Sundberg AK, et al. Intermediate-term outcomes with expanded criteria deceased donors in kidney transplantation: a spectrum or specter of quality? Ann Surg. 2006;243(5):594-601; discussion 601-603.
12. Antus B, Yao Y, Liu S, Song E, Lutz J, Heemann U. Contribution of androgens to chronic allograft nephropathy is mediated by dihydrotestosterone. Kidney Int. 2001;60(5):1955-1963.
13. Cecka JM. The UNOS Scientific Renal Transplant Registry--2000. Clin Transpl. 2000:1-18.
14. Lieber SR, Perez FV, Tabossi MR, et al. Effect of panel-reactive antibody in predicting crossmatch selection of cadaveric kidney recipients. Transplant Proc. 2007;39(2):429-431.
15. Singh D, Kiberd BA, West KA, et al. Importance of peak PRA in predicting the kidney transplant survival in highly sensitized patients. Transplant Proc. 2003;35(7):2395-2397.
16. Rao PS, Schaubel DE, Guidinger MK, et al. A comprehensive risk quantification score for deceased donor kidneys: the kidney donor risk index. Transplantation. 2009;88(2):231-236.
17. Cockfield SM, Moore RB, Todd G, Solez K, Gourishankar S. The prognostic utility of deceased donor implantation biopsy in determining function and graft survival after kidney transplantation. Transplantation. 2010;89(5):559-566.
18. Muruve NA, Steinbecker KM, Luger AM. Are wedge biopsies of cadaveric kidneys obtained at procurement reliable? Transplantation. 2000;69(11):2384-2348.
19. Wang HJ, Kjellstrand CM, Cockfield SM, Solez K. On the influence of sample size on the prognostic accuracy and reproducibility of renal transplant biopsy. Nephrol Dial Transplant. 1998;13(1):165- 172.
20. Bajwa M, Cho YW, Pham PT, et al. Donor biopsy and kidney transplant outcomes: an analysis using the Organ Procurement and Transplantation Network/United Network for Organ Sharing (OPTN/UNOS) database. Transplantation. 2007;84(11):1399-1405.
21. United States Renal Data System: The concise 2009 Annual Data Report http://www.usrds.org/2009/usrds_booklet_09.pdf. Accessed Sept 16, 2014.
22. Schold J, Srinivas TR, Sehgal AR, Meier-Kriesche HU. Half of kidney transplant candidates who are older than 60 years now placed on the waiting list will die before receiving a deceased-donor transplant. Clin J Am Soc Nephrol. 2009;4(7):1239-1245.
23. Merion RM, Ashby VB, Wolfe RA, et al. Deceased-donor characteristics and the survival benefit of kidney transplantation. JAMA. 2005;294(21):2726-2733.
24. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341(23):1725-1730.
25. Whiting JF, Woodward RS, Zavala EY, et al. Economic cost of expanded criteria donors in cadaveric renal transplantation: analysis of Medicare payments. Transplantation. 2000;70(5):755-760.
26. Saidi RF, Elias N, Kawai T, et al. Outcome of kidney transplantation using expanded criteria donors and donation after cardiac death kidneys: realities and costs. Am J Transplant. 2007;7(12):2769-2774.